While waiting for the FDA to grant marketing clearance on the Zargis Acoustic Cardioscan System (ZACâ„¢) - a product designed to assist primary-care physicians in the detection and analysis of suspected heart murmurs - Zargis Medical Corp. announced today that Thomas Miller has joined the Zargis Board of Directors.
An expert in the field of medical systems and healthcare solutions, Mr. Miller is president of Siemens Medical Solutions Health Services Corporation
"Mr. Miller brings to the table a long and successful career in the medical industry, and offers a unique perspective as a business leader - having both a technical background and experience in business development, marketing and sales," said Zargis President and CEO Shahram Hejazi.
"The ZAC system is one of the most exciting products I have come across in recent years," Mr. Miller
"And I am delighted to be part of Zargis
As president of Siemens Medical Solutions Health Services Corporation, Mr. Miller oversees Siemens health care information technology business worldwide.
holds an impressive professional track record within Siemens
and other multinational corporations.
During his initial 15 year tenure with Siemens, Mr. Miller headed up Siemens Medical's Magnetic Resonance product division, as well as Siemens Medical's U.S. sales and service organization.
Most recently, he was vice president of business development, for Siemens Medical Solutions in Erlangen, Germany.
In addition to his leadership positions at Siemens
, Mr. Miller
was also president and CEO of Carl Zeiss, Inc.
, the American subsidiary of the multi-billion dollar optical company, and simultaneously the general manager of the worldwide medical division of Carl Zeiss
, responsible for surgical microscopes and ophthalmology products.
Mr. Miller also served as president and CEO of Analogic Corporation, a manufacturer of components and subsystems for the healthcare and security industry.
Mr. Miller also co-founded a company, LightLab Imaging, to commercialize a new diagnostic imaging method called optical coherence tomography (OCT) enabling the acquisition and display of real-time ultra high-resolution cross sectional images with light.
During summer 2002, following successful initial clinical trials for vulnerable plaque imaging in coronary arteries, he
sold the operation to a Japanese company.
Mr. Miller holds a B.S. in Nuclear Engineering with a minor in English Literature from the University of Massachusetts and a master's degree from Harvard Medical School/MIT's joint program in Medical Physics.